ONKURE THERAPEUTICS, INC. (OKUR) Operating cash flow 2020–2025
ONKURE THERAPEUTICS, INC. (OKUR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$51.8MFY2025 · since FY2020: -$18.5M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -1.4% |
| FY2024 | -$51.1M | -48.0% |
| FY2023 | -$34.5M | +27.1% |
| FY2022 | -$47.4M | -24.7% |
| FY2021 | -$38.0M | -104.9% |
| FY2020 | -$18.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OKUR financial trends
OKUR RevenueOKUR Net incomeOKUR Net marginOKUR Gross profitOKUR Gross marginOKUR Operating incomeOKUR Operating marginOKUR Free cash flowOKUR Capital expendituresOKUR Return on equityOKUR Stock buybacksOKUR Dividends paidOKUR Total assetsOKUR Total liabilitiesOKUR Shareholders’ equityOKUR overview →